Dr. Alexander N. Slade
Claim this profileStony Brook University Medical Center
Affiliated Hospitals
Stony Brook University Medical Center
Stony Brook University Cancer Center
Clinical Trials Alexander N. Slade is currently running
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting
2 awards
Phase 3
10 criteria
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting
2 awards
Phase 3
More about Alexander N. Slade
Clinical Trial Related
7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Alexander N. Slade has experience with
- Radiation Therapy
- Apalutamide
- Degarelix
- Histrelin
- Bicalutamide
- Leuprolide
Breakdown of trials Alexander N. Slade has run
Prostate Cancer
Prostate Adenocarcinoma
Erectile Dysfunction
Bladder Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander N. Slade specialize in?
Alexander N. Slade focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Alexander N. Slade currently recruiting for clinical trials?
Yes, Alexander N. Slade is currently recruiting for 4 clinical trials in Stony Brook New York. If you're interested in participating, you should apply.
Are there any treatments that Alexander N. Slade has studied deeply?
Yes, Alexander N. Slade has studied treatments such as Radiation Therapy, Apalutamide, Degarelix.
What is the best way to schedule an appointment with Alexander N. Slade?
Apply for one of the trials that Alexander N. Slade is conducting.
What is the office address of Alexander N. Slade?
The office of Alexander N. Slade is located at: Stony Brook University Medical Center, Stony Brook, New York 11794 United States. This is the address for their practice at the Stony Brook University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.